Cancer cachexia (CC) accounts for 20%–40% of cancer-related deaths. Mitochondrial
aberrations have been shown to precede muscle atrophy in different atrophy models …

Cancer-associated cachexia is a complex metabolic condition characterized by the
progressive loss of body fat and deterioration of muscle mass. Although the cellular and …

Cancer cachexia is a frequently neglected debilitating syndrome that, beyond representing a
primary cause of death and cancer therapy failure, negatively impacts on patients' quality of …

Background Cancer cachexia is largely irreversible, at least via nutritional means, and
responsible for 20–40% of cancer‐related deaths. Therefore, preventive measures are of …

Background Chemotherapy induces a cachectic‐like phenotype, accompanied by skeletal
muscle wasting, weakness and mitochondrial dysfunction. Peroxisome proliferator‐activated …

Cancer patients commonly suffer from cachexia, a syndrome in which tumors induce
metabolic changes in the host that lead to massive loss in skeletal muscle mass. Using a …

Background More than 650 million people are obese (BMI> 30) worldwide, which increases
their risk for several metabolic diseases and cancer. While cachexia and obesity are at …

Cancer cachexia is a multifactorial syndrome characterized by anorexia, weight loss and
muscle wasting that impairs patients' quality of life and survival. Aim of this work was to …

Cancer-cachexia (CC) is a wasting condition directly responsible for 20–40% of cancer-
related deaths. The mechanisms controlling development of CC-induced muscle wasting …

Cancer cachexia is a multifactorial syndrome characterized by continuous body wasting and
loss of skeletal muscle. Impaired mitochondria function is closely associated with muscle …